Scope: Create a lidocaine buffing device that can be mixed by the end-user prior to patient application.
Challenge: Very cost-sensitive, minimal training for the users, high volume, 510(k)
Outcome: From idea to 510(k) approval in two years, on a tight budget. Acquired by a strategic partner in 2014. Spun out in 2018 for next-generation development.
Phoenix DeVentures has manufactured more than 2 million units